查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1291392

基於腫瘤學的體內CRO市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

2022年，全球基於腫瘤學的體內CRO市場規模達到11億美元。展望未來，IMARC Group預計到2028年，市場規模將達到18億美元，在2023-2028年期間表現出7.65%的成長率（CAGR）。

腫瘤學是指使用活體組織切片、內視鏡、X光、電腦斷層掃描（CT）、磁共振成像（MRI）、正電子發射斷層掃描（PET）和超音波研究、診斷和治療癌症的一個醫學分支。它為患者提供荷爾蒙療法、免疫療法、放射療法和口服療法，以容忍和緩解癌症的副作用。目前，由於契約研究組織（CRO）開發了一些用於治療癌症的研究性化合物，全球範圍內對基於腫瘤學的體內CRO的需求有所上升。

基於腫瘤學的體內CRO市場趨勢：

世界各地癌症發病率的成長是推動市場發展的關鍵因素之一。此外，全球多個國家的政府正在廣泛地投資於研究和開發（R&D）活動。這一點，加上契約研究組織（CRO）在癌症治療方面不斷增加的專業知識，正在推動市場的成長。此外，用於操縱脫氧核糖核酸（DNA）和改變生物體特徵的基因工程創新也在增加。這一點，再加上對腫瘤基因研究的日益重視，以調節細胞的增殖、生長和分化，對市場產生了積極影響。除此之外，藥品的廣泛供應，以及不斷擴大的醫療保健行業，正在催化全球對基於腫瘤學的體內CRO的需求。除此之外，與內部研究相比，契約研究組織（CRO）提供的成本效益為行業投資者提供了有利可圖的成長機會。此外，為確保癌症患者的安全，醫療行業採用遠程醫療和虛擬臨床試驗的情況也在增加。這預計將促進市場的成長。

本報告回答的關鍵問題：

  • 2022年，全球基於腫瘤學的體內CRO市場的規模是多少？
  • 2023-2028年，全球基於腫瘤學的體內CRO市場的預期成長率是多少？
  • 推動全球基於腫瘤學的體內CRO市場的關鍵因素是什麼？
  • COVID-19對全球腫瘤學體內CRO市場的影響是什麼？
  • 基於適應症的全球腫瘤學體內CRO市場的詳細情形是怎樣的？
  • 基於模型的全球腫瘤學體內CRO市場的詳細情形如何？
  • 全球基於腫瘤學的體內CRO市場的主要地區有哪些？
  • 誰是全球腫瘤學體內CRO市場的主要參與者/公司？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球基於腫瘤學的體內CRO市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按適應症分類的市場

  • 血癌
    • 市場趨勢
    • 市場預測
  • 固體腫瘤
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：按模式分類的市場

  • 合成基因
    • 市場趨勢
    • 市場預測
  • 異種移植
    • 市場趨勢
    • 市場預測
  • 患者衍生的異體移植(PDX)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章：按應用分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 康復中心
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Champions Oncology Inc.
    • Charles River Laboratories International Inc.
    • Crown Bioscience Inc.
    • Eurofins Scientific
    • Evotec SE
    • ICON Plc
    • Labcorp Drug Development (Laboratory Corporation of America Holdings)
    • Living Tumor Laboratory
    • Taconic Biosciences Inc.
    • The Jackson Laboratory
    • WuXi AppTec
    • Xentech
Product Code: SR112023A5438

Market Overview:

The global oncology based in-vivo CRO market size reached US$ 1.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.

Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.

Oncology Based In-Vivo CRO Market Trends:

The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology based in-vivo CRO market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on indication, model and application.

Breakup by Indication:

  • Blood Cancer
  • Solid Tumors
  • Others

Breakup by Model:

  • Syngeneic
  • Xenograft
  • Patient Derived Xenograft (PDX)
  • Others

Breakup by Application:

  • Hospitals
  • Rehabilitation Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.

Key Questions Answered in This Report:

  • What was the size of the global oncology based in-vivo CRO market in 2022?
  • What is the expected growth rate of the global oncology based in-vivo CRO market during 2023-2028?
  • What are the key factors driving the global oncology based in-vivo CRO market?
  • What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
  • What is the breakup of the global oncology based in-vivo CRO market based on the indication?
  • What is the breakup of the global oncology based in-vivo CRO market based on the model?
  • What are the key regions in the global oncology based in-vivo CRO market?
  • Who are the key players/companies in the global oncology based in-vivo CRO market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Oncology Based In-Vivo CRO Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Indication

  • 6.1  Blood Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Solid Tumors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Model

  • 7.1  Syngeneic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Xenograft
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Patient Derived Xenograft (PDX)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Application

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Rehabilitation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Champions Oncology Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2  Charles River Laboratories International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Crown Bioscience Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4  Eurofins Scientific
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Evotec SE
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  ICON Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8  Living Tumor Laboratory
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Taconic Biosciences Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10  The Jackson Laboratory
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11  WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12  Xentech
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2022
  • Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
  • Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
  • Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million US$), 2023-2028
  • Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
  • Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players